Company page
Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a public company traded on the American market under the ticker VKTX. The company has a market capitalization of approximately $4.04 billion. Viking Therapeutics focuses on developing innovative therapies for metabolic and endocrine disorders.
- Ticker
- VKTX:NASDAQ
- Asset type
- Stock
- Market cap
- $3.95B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD